4M9-20051-05147
4 vaccinations
3 coded responses
36 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 500 / IA
- Registered
- 2020-12-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-31
Registered in v-safe
-
2020-12-31
Dose 1 — Pfizer-BioNTech
- 2020-12-31
- 2021-01-01
- 2021-01-02
- 2021-01-03
- 2021-01-04
- 2021-01-06
- 2021-01-07
- 2021-01-14
-
2021-01-21
Dose 2 — Pfizer-BioNTech
- 2021-01-28
-
2021-02-04
Survey response — day 14, dose 2MedDRA: Nasopharyngitis, SARS-CoV-2 test negative — Feeling: Good · Be unable to workFree text: Upper respiratory cold. Covid negative.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-11
- 2021-02-18
- 2021-02-25
- 2021-03-04
- 2021-04-22
-
2021-07-22
Survey response — 6 months, dose 2MedDRA: Electrocardiogram ST segment elevation, Electrocardiogram abnormal, Sinus tachycardia — Feeling: Good · Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Had an irregular EKG with sinus tachycardia and ST elevationMedDRA releases: 2024-11 · check-in free text available
-
2021-07-22
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-28
-
2021-09-25
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2021-09-29
- 2021-09-30
- 2021-10-01
- 2021-10-02
- 2021-10-09
- 2021-10-16
- 2021-10-23
- 2021-10-30
- 2021-11-06
-
2021-12-25
Survey response — 3 months, dose 3MedDRA: Nausea, Tachycardia, Vomiting — Feeling: Good · Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Tachycardia with nausea and vomitingMedDRA releases: 2024-11 · check-in free text available
-
2021-12-25
Report sent to call center — 3 months, dose 3Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · 1 call case(s)
-
2021-12-27
Call successfulParticipant prefers to complete VAERS report online
- 2022-03-26
-
2022-09-23
Dose 4 — Pfizer-BioNTech
- 2022-09-25
- 2022-10-02
- 2022-10-07
- 2022-10-14
- 2022-10-21
- 2022-10-28
- 2022-11-04
- 2022-12-25
- 2023-03-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-31 | Pfizer-BioNTech | |
| 2 | 2021-01-21 | Pfizer-BioNTech | |
| 3 | 2021-09-25 | Pfizer-BioNTech | Flu |
| 4 | 2022-09-23 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-07-22 | Successful | Participant prefers to complete VAERS report online |
| 2021-12-25 | Successful 2021-12-27 |
Participant prefers to complete VAERS report online |
Free text
Release 3 — day 14, dose 2
Symptoms: Upper respiratory cold. Covid negative.
Release 9 — 6 months, dose 2
Symptoms: Had an irregular EKG with sinus tachycardia and ST elevation
Release 10 — 3 months, dose 3
Symptoms: Tachycardia with nausea and vomiting
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Electrocardiogram abnormal | · | · | ✓ |
| SD | Electrocardiogram ST segment elevation | · | · | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | ✓ | ✓ | ✓ |
| SD | Sinus tachycardia | · | · | ✓ |
| SD | Tachycardia | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release